Inhibition of mammalian dna polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine

This publication has 9 references indexed in Scilit:

• Clinical pharmacokinetics of 3′-azido-3′-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′-amino-3′-deoxythymidine
  Clinical Pharmacology & Therapeutics, 1992
• Primary structure of the catalytic subunit of calf thymus DNA polymerase .delta.: sequence similarities with other DNA polymerases
  Biochemistry, 1991
• Fidelity of mammalian DNA replication and replicative DNA polymerases
  Biochemistry, 1991
• Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in human peripheral blood mononuclear cells
  Biochemical Pharmacology, 1990
• Incorporation of 3’-Azido-3’-deoxythymidine into Cellular DNA and Its Removal in a Human Leukemic Cell Line
  Cancer Communications, 1990
• Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
  New England Journal of Medicine, 1989
• Phosphorylation, anti-HIV activity and cytotoxicity of 3′-fluorothymidine
  Biochemical and Biophysical Research Communications, 1988
• Selective inhibition of the 3' to 5' exonuclease activity associated with DNA polymerases: a mechanism of mutagenesis
  Biochemistry, 1977
• Studies of Phosphorylation. III. Selective Phosphorylation of Unprotected Nucleosides
  Bulletin of the Chemical Society of Japan, 1969